类风湿关节炎与肠道通透性增加及细菌移位相关,控制炎症后可逆转
在20例RA患者和20例年龄性别匹配对照的结肠活检中,RA患者ZO-1蛋白表达低于对照(平均评分1.6±0.56 vs 2.0±0.43,p=0.01)。另一队列59例RA和33例健康对照显示RA患者血清LBP和sCD14升高,且与DAS28相关;bDMARD应答者LBP和sCD14显著降低,而bDMARD无应答者和csDMARD治疗者未见此变化。
要点
- RA患者结肠ZO-1蛋白表达低于对照,occludin和claudin-2无显著差异。
- RA患者血清LBP和sCD14高于对照,且与DAS28相关(r=0.61和r=0.57)。
- bDMARD应答者LBP和sCD14显著降低,bDMARD无应答者和csDMARD治疗者未见此变化。
核心结论
- RA患者存在结肠紧密连接蛋白改变和肠道通透性血清生物标志物升高。
- 肠道通透性血清标志物与疾病活动度及bDMARD应答存在相关性。
- 这些结果提示RA中肠道完整性受损与全身炎症之间存在关联。
研究设计与样本
- 在20例RA患者和20例年龄性别匹配对照的结肠活检中,用免疫组化定量ZO-1、occludin和claudin-2,由两名盲法独立读者评估染色强度。
- 另一队列用ELISA评估59例RA患者(21例未用DMARD,其中17例在引入csDMARD前后;38例重度RA在引入bDMARD前后)和33例健康对照的血清LBP、sCD14和zonulin相关蛋白(ZRP)。
主要发现
- RA患者结肠ZO-1蛋白表达低于对照(平均评分±SEM为1.6±0.56 vs 2.0±0.43,p=0.01),occludin和claudin-2未见显著差异。
- RA患者血清LBP和sCD14浓度高于对照。
- LBP和sCD14水平与DAS28显著相关(分别为r=0.61,p=0.005和r=0.57,p=0.01),ZRP则否。
- bDMARD应答者LBP和sCD14浓度显著降低,bDMARD无应答者和csDMARD治疗者未见此变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: to assess how rheumatoid arthritis (RA) and Disease Modifying Anti Rheumatic Drugs (DMARDs) affect gut permeability. METHODS: to explore colonic mucosa integrity, tight junction proteins ZO-1, occludin and claudin 2 were quantified by immunohistochemistry on colonic biopsies in 20 RA patients and 20 age- and sex-matched controls. Staining intensity was assessed by two blinded independent readers. To explore intestinal permeability, serum concentrations of LPS-binding protein (LBP), sCD14 and zonulin-related proteins (ZRP) were evaluated by ELISA in another cohort of 59 RA: 21 patients naive of DMARDs (17 before and after introduction of a conventional synthetic (cs) DMARDs), 38 patients with severe RA (before and after introduction of a biological (b) DMARDs), and 33 healthy controls. RESULTS: Z0-1 protein was less expressed in colon of RA patients than controls (mean score ± SEM of 1.6 ± 0.56 vs 2.0 ± 0.43; p= 0.01), while no significant difference was detected for occludin and claudin-2. RA patients had higher serum LBP and sCD14 concentrations than controls. LBP and sCD14 levels were significantly correlated with DAS28 (r = 0.61, p= 0.005 and r = 0.57, p= 0.01, respectively) while ZRP did not. bDMARD responders had significantly reduced LBP and sCD14 concentrations unlike bDMARDs non-responders and patients treated with csDMARDs. CONCLUSION: RA patients have altered colonic tight junction proteins and increased serum biomarkers of intestinal permeability. There was a correlation between serological markers of intestinal permeability and disease activity as well as bDMARD response. These results suggest a link between impaired gut integrity and systemic inflammation in RA.
引用
- Audo R, Sanchez P, Rivière B, et al. Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control. Rheumatology (Oxford). 2022. PMID: 35946514. doi:10.1093/rheumatology/keac454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。